Nittoh Corporation (XNGO:1738)

Akoya Biosciences Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-	594	377	328	399	360
Depreciation & Amortization	-	94	54	50	50	47
Loss (Gain) From Sale of Assets	-	-289	81	48	34	-
Other Operating Activities	-	-165	-100	-161	-133	-78
Change in Accounts Receivable	-	153	-148	18	-31	-112
Change in Inventory	-	-79	3	-165	-15	-163
Change in Accounts Payable	-	54	-46	67	20	59
Change in Other Net Operating Assets	-	-57	138	-2	17	-25
Operating Cash Flow	-	305	359	183	341	88
Operating Cash Flow Growth	-	-15.04%	96.17%	-46.33%	287.50%	-75.82%
Capital Expenditures	-	-315	-570	-131	-229	-230
Sale of Property, Plant & Equipment	-	496	-	-	-	-
Sale (Purchase) of Intangibles	-	-	-5	-3	-	-
Other Investing Activities	-	-6	-2	-1	-2	-2
Investing Cash Flow	-	175	-577	-132	-234	-232
Short-Term Debt Issued	-	-	-	-	-	200
Long-Term Debt Issued	-	-	600	200	-	-
Total Debt Issued	-	-	600	200	-	200
Long-Term Debt Repaid	-	-447	-136	-111	-70	-70
Total Debt Repaid	-	-447	-136	-111	-70	-70
Net Debt Issued (Repaid)	-	-447	464	89	-70	130
Dividends Paid	-	-64	-60	-56	-48	-52
Other Financing Activities	-	-2	-1	-1	-1	-2
Financing Cash Flow	-	-513	403	32	-119	76
Miscellaneous Cash Flow Adjustments	-	1	-	1	1	1
Net Cash Flow	-	-32	185	84	-11	-67
Free Cash Flow	-	-10	-211	52	112	-142
Free Cash Flow Growth	-	-	-	-53.57%	-	-
Free Cash Flow Margin	-	-0.10%	-2.08%	0.54%	1.20%	-1.65%
Free Cash Flow Per Share	-	-2.47	-52.06	12.83	27.63	-35.03
Cash Interest Paid	-	8	6	5	4	3
Cash Income Tax Paid	-	165	100	162	134	78
Levered Free Cash Flow	-	-46.25	-263.63	-27.88	48.88	-184
Unlevered Free Cash Flow	-	-41.25	-259.88	-25.38	51.38	-182.13
Change in Working Capital	-	71	-53	-82	-9	-241

Source: S&P Global Market Intelligence. Standard template. Financial Sources.